Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
However, this study also has some limitations
What is unique is that these products are tested on GLP-1 users before they launch to prove that theyre effective
From 2023 to 2025, MedStar Health served as a research site for the ATTAIN-1 trial, a phase III double-blind, placebo-controlled study of the safety and efficacy of the GLP-1 receptor agonist drug orforglipron
Instagram and TikTok say selling the drug on their platforms is banned and promotional content will be taken down
This is not a dosing guide, and the research product is not for human use
US$ 24.83
US$ 27.97
US$ 23.02
US$ 28.86
US$ 25.97
US$ 27.00
